Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis
- 29 July 1996
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 67 (3) , 423-429
- https://doi.org/10.1002/(sici)1097-0215(19960729)67:3<423::aid-ijc18>3.0.co;2-8
Abstract
We have examined the role of urokinase receptor (uPAR) in tumor invasion and metastasis by developing a homologous model of uPAR overexpression in a rat breast cancer cell line (Mat B III) using gene transfer technique. Control (pRc‐CMV) and experimental plasmid (pRc‐uPAR‐S) were transfected into Mat B III cells by using Lipofectin reagent. Levels of uPAR production were accessed by Northern blotting, immunofluorescence, receptor binding and ELISA. At least 3 experimental clones (pRc‐uPAR‐S), expressing 3‐ to 5‐fold higher levels of uPAR than control (pRc‐CMV), were selected for further analysis. Experimental cells overexpressing uPAR showed a 4‐ to 5‐fold higher invasive capacity compared with control cells in a Boyden chamber invasion assay. Both control and experimental cells (1 × 106 cells) were injected into the mammary fat pad of syngeneic female Fischer rats. Animals were sacrificed at timed intervals and evaluated for the development of tumor growth and metastasis. Animals receiving cells overexpressing uPAR had significantly larger tumor volume and weight throughout our study. Furthermore, due to increased uPAR expression, experimental animals developed large metastatic lesions in liver, spleen and lymph nodes. Our results therefore demonstrate the role of uPAR in tumor progression, due to its ability to localize uPA within the tumor cell milieu. © 1996 Wiley‐Liss, Inc.Keywords
This publication has 12 references indexed in Scilit:
- Prevention of prostate‐cancer metastasis in vivo by a novel synthetic inhibitor of urokinase‐type plasminogen activator (uPA)International Journal of Cancer, 1995
- Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC-3The Prostate, 1995
- Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancerInternational Journal of Cancer, 1995
- The etiopathogenesis of breast cancer preventionCancer Letters, 1995
- The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasionFibrinolysis, 1994
- Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblastsFEBS Letters, 1994
- Prevention of metastasis by inhibition of the urokinase receptor.Proceedings of the National Academy of Sciences, 1993
- Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract.The Journal of cell biology, 1991
- Clinical Relevance of the Urokinase-Type and Tissue-Type Plasminogen Activators and of Their Type 1 Inhibitor in Breast CancerSeminars in Thrombosis and Hemostasis, 1991
- An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cellsBiochemical and Biophysical Research Communications, 1990